Clinical Trials Directory

Trials / Terminated

TerminatedNCT03865264

Living Organ Donor Recovery Enhancement Program

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Baylor Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to test if using these living donor-specific pre-transplant resources would lead to a better and faster recovery post-transplant.

Detailed description

Donor safety and outcomes are the chief concerns of programs performing living donor liver and kidney transplantation. The protection of donors from physical and emotional harm has been a fundamental principle in living donor liver and kidney donation from the beginning. The safety of living donor hepatectomy and nephrectomy has been established. The risks associated with the donation have been deemed acceptable by the transplant community. The investigators would like to move beyond the safety of the operation and address the most important post-operative issues that potentially cause donors physical and emotional stress: these include pain control, appropriate nutrition for optimal liver regeneration and physical/functional recovery, fatigue, time to return to normal physical and work activity, and difficulties coping with recovery and any possible complications. The goal of conducting this study is to create a program of pre- and post-operative interventions to enhance recovery so that patients can return to their normal quality of life as soon as possible. Currently there is no literature on programs to enhance living donor care and recovery. This study will be conducted to determine if interventions during the pre-operative (a minimum of four weeks in an exercise program), intra-operative (anesthesia), and post-operative (pain management) stages have an effect on liver and kidney donor patients' quality of life and return to baseline functional status.

Conditions

Interventions

TypeNameDescription
OTHERRecovery Enhancement ProgramBehavioral, nutritional, physical and opioid-reduction pain medication

Timeline

Start date
2017-04-20
Primary completion
2024-01-22
Completion
2024-01-22
First posted
2019-03-06
Last updated
2026-01-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03865264. Inclusion in this directory is not an endorsement.